Literature DB >> 9442940

Pathogenesis and clinical signs of equine herpesvirus-1 in experimentally infected ponies in vivo.

G A Sutton1, L Viel, P S Carman, B L Boag.   

Abstract

Equine herpesvirus-1 (EHV-1) causes respiratory disease, neonatal death, abortion and neurologic disease. The main purpose of this study was to identify viral antigen in respiratory tract samples by immunoperoxidase staining. Six pony foals were selected on the basis of demonstrating seronegativity to EHV-1 by virus neutralization and housed in isolation. They were infected experimentally by administering EHV-1 nebulized ultrasonically through a face mask. Successful infection was clinically apparent as each of the foals had febrile responses, nasal discharge, and enlarged submandibular lymph nodes. Sporadic coughing was also heard. EHV-1 was isolated from nasopharyngeal swabs of 4/6 ponies and seroconversion was demonstrated in all foals. Bronchoscopic examination of the large airways revealed hyperemia. The incidence of recovery of Actinobacillus suis from nasopharyngeal swabs increased initially, with recovery of Streptococcus zooepidemicus isolates predominating at 3 wk post-infection. Cytology brushes were used to sequentially sample the respiratory tract of the infected ponies at the nasopharynx, mid-trachea and the mainstem bronchus. Bronchoalveolar lavage provided lung cells. Immunocytochemistry techniques were applied to both types of samples to locate EHV-1 antigen. Indirect immunoperoxidase staining of samples utilizing monoclonal antibodies specific for EHV-1 demonstrated viral antigen associated with cellular debris, primarily in the nasopharyngeal samples on days 3-9 post-infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442940      PMCID: PMC1189442     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  22 in total

1.  An epizootic of Mycoplasma ovipneumoniae infection in captive Dall's sheep (Ovis dalli dalli).

Authors:  S R Black; I K Barker; K G Mehren; G J Crawshaw; S Rosendal; L Ruhnke; J Thorsen; P S Carman
Journal:  J Wildl Dis       Date:  1988-10       Impact factor: 1.535

2.  Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1.

Authors:  D Tewari; J S Gibson; J D Slater; T O'Neill; D Hannant; G P Allen; H J Field
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Another fence jumped in the EHV-1 stakes.

Authors:  N Edington
Journal:  Equine Vet J       Date:  1994-11       Impact factor: 2.888

4.  Rapid subtyping of equine herpesvirus 1 with monoclonal antibodies.

Authors:  M R Yeargan; G P Allen; J T Bryans
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

5.  The effect of EHV-1 infection upon circulating leucocyte populations in the natural equine host.

Authors:  J McCulloch; S A Williamson; S J Powis; N Edington
Journal:  Vet Microbiol       Date:  1993-10       Impact factor: 3.293

Review 6.  The equine herpesviruses.

Authors:  E N Ostlund
Journal:  Vet Clin North Am Equine Pract       Date:  1993-08       Impact factor: 1.792

7.  Immune responses of specific pathogen free foals to EHV-1 infection.

Authors:  Y C Chong; W P Duffus
Journal:  Vet Microbiol       Date:  1992-10       Impact factor: 3.293

8.  The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses.

Authors:  N Edington; H M Welch; L Griffiths
Journal:  Equine Vet J       Date:  1994-03       Impact factor: 2.888

9.  Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies.

Authors:  J H Kydd; K C Smith; D Hannant; G J Livesay; J A Mumford
Journal:  Equine Vet J       Date:  1994-11       Impact factor: 2.888

10.  Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity.

Authors:  J H Kydd; K C Smith; D Hannant; G J Livesay; J A Mumford
Journal:  Equine Vet J       Date:  1994-11       Impact factor: 2.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.